AbbVie to acquire Allergan in “transformative move”
Abbvie to acquire Allergan after entering into a definitive transaction agreement under which AbbVie will acquire the company in a cash and stock transaction...
Novartis acquires IFM Tre
Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...
GHO Capital acquires Sterling Pharma Solutions
European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...
Healthtech M&A and IPO Activity
The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...
DoseCare acquires Biodose
DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...
UK pharma pressing ahead with M&As in 2019
The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...
Sanofi and Denali join forces on inflammatory disease drugs
Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...
AstraZeneca divests rights for Nexium and Vimovo to Grünenthal
AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...
Mundipharma acquires biosimilars development company
The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...
BioIVT acquires CTLS a UK blood donor facility
BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...
Latest articles
NICE approves ribociclib with fulvestrant for breast cancer
Patients to have a further drug combination option on Cancer Drugs Fund as NICE approves ribociclib with fulvestrant for breast cancer in draft guidance.
The positive...
New research highlights the relationship between sleep medication and dementia
New research presented at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles highlights the relationship between sleep medication and dementia. It examines the...
ViiV Healthcare to showcase innovation in HIV science
ViiV Healthcare has announced that 20 abstracts from its portfolio of late-stage pipeline and authorised HIV treatments will be presented at the 10th International...
Popular articles
ViiV Healthcare to showcase innovation in HIV science
ViiV Healthcare has announced that 20 abstracts from its portfolio of late-stage pipeline and authorised HIV treatments will be presented at the 10th International...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Driving patient centricity in patient-facing programmes
How one company created a core proposition which puts the patient first in all the work it does. All companies within the healthcare sector...
New research highlights the relationship between sleep medication and dementia
New research presented at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles highlights the relationship between sleep medication and dementia. It examines the...
Engaging patients earlier in clinical development
Successful patient engagement is essential to the clinical development process. How can companies get it right? Patient and public engagement in clinical research means that...